Package 63323-304-94

Brand: piperacillin and tazobactam

Generic: piperacillin sodium and tazobactam sodium
NDC Package

Package Facts

Identity

Package NDC 63323-304-94
Digits Only 6332330494
Product NDC 63323-304
Description

1 BOTTLE in 1 CARTON (63323-304-94) / 180 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2011-05-31
Brand piperacillin and tazobactam
Generic piperacillin sodium and tazobactam sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "71554f30-2eda-48b2-b89a-82a58fcfb421", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["2cfa6723-175b-4c4d-8212-266844b07610"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63323-304-94)  / 180 mL in 1 BOTTLE", "package_ndc": "63323-304-94", "marketing_start_date": "20110531"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-304_71554f30-2eda-48b2-b89a-82a58fcfb421", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-304", "generic_name": "Piperacillin Sodium and Tazobactam Sodium", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/180mL"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/180mL"}], "application_number": "ANDA090498", "marketing_category": "ANDA", "marketing_start_date": "20110531", "listing_expiration_date": "20261231"}